Periodontal Disease, Matrix Metalloproteinases and Chemically Modified Tetracyclines

Article English OPEN
Steinsvoll, Svein (2011)
  • Publisher: Microbial Ecology in Health and Disease
  • Journal: Microbial Ecology in Health and Disease (issn: 1651-2235, eissn: 1651-2235)
  • Related identifiers: doi: 10.3402/mehd.v16i1.7949

Matrix metalloproteinases (MMPs) are crucial in the degradation of the main components in the extracellular matrix and thereby play important roles in cell migration, wound healing and tissue remodelling. MMPs have pathogenic roles in arthritis, periodontitis, hepatitis, glomerulonephritis, atherosclerosis and cancer cell invasion. MMPs are activators of pro-inflammatory mediators that occur in latent forms, such as interleukin (IL)-1β, membrane-bound tumour necrosis factor (TNF) and different MMPs. To regulate their action, MMPs are secreted in latent, inactive pro-enzyme forms, with plasmin and other MMPs as likely activators. MMP activity is further modulated by the tissue inhibitors of metalloproteinases (TIMP-1, -2, -3 and -4), which partly control and stabilize MMPs. In normal steady-state tissues, only low levels of MMPs are detected intra- and extra-cellularly because MMPs are tightly regulated at the level of transcription and secretion. In inflamed periodontal tissue, numbers of cells expressing MMPs are increased as compared with healthy gingival tissue. Recently, novel nonantimicrobial MMP-inhibitory effects of tetracyclines were discovered, and subsequently a panel of chemically modified non-antimicrobial tetracyclines (CMTs) was developed. This paper discusses these new drugs and their possible biological effects in periodontal disease.
  • References (45)
    45 references, page 1 of 5

    1. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976; 33: 235 /49.

    2. Zachrisson BU, Schultz-Haudt SD. A comparative histological study of clinically normal and chronically inflamed gingivae from the same individuals. Odontol Tidskr 1968; 6: 179 /92.

    3. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 75 /7.

    4. Nilsson G, Metcalfe DD. Contemporary issues in mast cell biology. Allergy Asthma Proc 1996; 17: 59 /63.

    5. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381: 77 /80.

    6. Abraham SN, Arock M. Mast cells and basophils in innate immunity. Semin Immunol 1998; 10: 373 /81.

    7. Lin T-J, Befus AD. Mast cells and eosinophils in mucosal defenses and pathogenesis. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. San Diego: Academic Press, 1999: 469 /82.

    8. Myint M, Steinsvoll S, Yuan ZN, Johne B, Helgeland K, Schenck K. Highly increased numbers of leukocytes in inflamed gingiva from patients with HIV infection. AIDS 2002; 16: 235 / 43.

    9. Galli SJ. Mast cells and basophils. Curr Opin Hematol 2000; 7: 32 /9.

    10. Winkler JR, Robertson PB. Periodontal disease associated with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992; 73: 145 /50.

  • Metrics
    No metrics available
Share - Bookmark